## ¿En qué tipo de investigación ha participado BMC? A continuación se muestran los estudios de accidentes cerebrovasculares en los que BMC participó en los últimos años. Puede hacer clic en un logotipo a continuación o en el nombre de un estudio en el menú de la izquierda para obtener más información sobre estudios individuales. Se incluyeron los resultados de los estudios que finalizaron la inscripción de pacientes y con los datos publicados disponibles. [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/aruba-study.jpg)](/stroke-and-cerebrovascular-center/services/arteriovenous-malformations-avms/aruba-study) [**ARUBA** : ensayo clínico multicéntrico aleatorizado de MAV cerebrales no rotas](/stroke-and-cerebrovascular-center/services/arteriovenous-malformations-avms/aruba-study) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/atach-II.jpg)](/stroke-and-cerebrovascular-center/research/completed-studies/atach2) [**ATACH2** - Tratamiento antihipertensivo de la hemorragia cerebral aguda](/stroke-and-cerebrovascular-center/research/completed-studies/atach2) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/CAA.jpg)](/stroke-and-cerebrovascular-center/research/completed-studies/caa) [**CAA** : un estudio de fase 2 para evaluar la seguridad, tolerabilidad, farmacocinética y eficacia de ponezumab en sujetos adultos con probable angiopatía amiloide cerebral](/stroke-and-cerebrovascular-center/research/completed-studies/caa) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/CONSCIOUS3_1_.jpg)](/stroke-and-cerebrovascular-center/research/completed-studies/conscious-3) [**CONSCIOUS3** : ensayo aleatorizado de clazosentán en pacientes con hemorragia subaracnoidea aneurismática sometidos a enrollamiento endovascular](/stroke-and-cerebrovascular-center/research/completed-studies/conscious-3) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/milestone-DALF.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/dalf-ps-1016-dalfampridine-patients) [**DALF-PS-1016** - Dalfampridina en pacientes con déficit crónico después de un accidente cerebrovascular isquémico](/stroke-and-cerebrovascular-center/research/completed-studies/dalf-ps-1016-dalfampridine-patients) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/DIAS4.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/dias4) [**DIAS4** - Desmoteplasa en accidente cerebrovascular isquémico agudo](/stroke-and-cerebrovascular-center/research/completed-studies/dias4) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/isis.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/iris) [**IRIS** - Intervención de resistencia a la insulina después de un ensayo de accidente cerebrovascular](/stroke-and-cerebrovascular-center/research/completed-studies/iris) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/marinus.png)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/marinus) [**MARINUS** : un estudio doble ciego, aleatorizado y controlado con placebo para evaluar la seguridad, tolerabilidad, eficacia y farmacocinética de la ganaxolona intravenosa como terapia adyuvante para tratar sujetos con estado epiléptico.](/stroke-and-cerebrovascular-center/research/marinus) --- ![maxQ](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/maxq-ai.jpg) [**MaxQ-AI** : recopilación retrospectiva de imágenes de TC de cabeza sin contraste para la evaluación clínica del software de la familia MaxQ-AI Accipio](/stroke-and-cerebrovascular-center/research/completed-studies/maxq-ai) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/mariss.jpg)](/stroke-and-cerebrovascular-center/research/mariss) [**MaRISS** : estudio de accidente cerebrovascular leve y que mejora rápidamente](/stroke-and-cerebrovascular-center/research/mariss-mild-and-rapidly-improving-stroke-study) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/mr-rescue.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/mr-rescue) [**MR RESCUE** : un ensayo de selección de imágenes y tratamiento endovascular para el accidente cerebrovascular isquémico](/stroke-and-cerebrovascular-center/research/completed-studies/mr-rescue) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/spotrias-MRWITNESS.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/mr-witness) [**MR WITNESS** : trombólisis intravenosa con alteplasa en pacientes seleccionados por resonancia magnética](/stroke-and-cerebrovascular-center/research/mr-witness-intravenous-thrombolysis-alteplase-mri) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/multistem.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/multistem) [**MULTISTEM** - Ensayo de eficacia y seguridad de fase 2 doble ciego, aleatorizado y controlado con placebo de MultiStem en adultos con accidente cerebrovascular isquémico](/stroke-and-cerebrovascular-center/research/completed-studies/multistem) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/navigate-esus.png)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/navigate-esus) [**NAVIGATE-ESUS** - Prevención secundaria de ictus en pacientes con ESUS reciente](/stroke-and-cerebrovascular-center/research/navigate-esus-secondary-prevention-stroke-patients-recent) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/point.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/point) [**PUNTO** - Inhibición orientada a plaquetas en nuevos AIT y accidente cerebrovascular isquémico menor](/stroke-and-cerebrovascular-center/research/point-platelet-oriented-inhibition-new-tia-and-minor) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/university-of-calgary.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/predict) [**PREDICT** : predicción del crecimiento y resultado del hematoma en hemorragia intracerevral mediante tomografía computarizada en bolo de contraste](/stroke-and-cerebrovascular-center/research/completed-studies/predict) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/profess.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/profess) [**PROFESS** - Régimen de prevención para evitar de forma eficaz los segundos accidentes cerebrovasculares](/stroke-and-cerebrovascular-center/research/completed-studies/profess) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/status-trial.png)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/sage-547-301) [**SAGE 547-301** : ensayo clínico aleatorizado de fase 3 para evaluar la eficacia y seguridad de la inyección de SAGE-547 en el tratamiento de sujetos con estado epiléptico superrefractario](/stroke-and-cerebrovascular-center/research/sage-547-301) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/status-trial.png)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/sage-547-302) [**SAGE 547-302** : para evaluar el uso de etiqueta abierta de SAGE-547 (alopregnanolona) en el tratamiento de sujetos con estado epiléptico superrefractario](/stroke-and-cerebrovascular-center/research/sage-547-302) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/SOCRATES.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/socrates-acute-stroke-or-transient) [**SÓCRATES** : accidente cerebrovascular agudo o ataque isquémico transitorio tratado con aspirina o ticagrelor y resultados de los pacientes](/stroke-and-cerebrovascular-center/research/completed-studies/socrates-acute-stroke-or-transient) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/sps3.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/sps3) [**SPS3** - Prevención secundaria de pequeños accidentes cerebrovasculares subcorticales](/stroke-and-cerebrovascular-center/research/completed-studies/sps3) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/team-trial-on-endovascular.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/team) [**EQUIPO** - Un ensayo sobre aneurismas intracraneales no rotos](/stroke-and-cerebrovascular-center/research/completed-studies/team) --- [![](/sites/default/files/Patient_Care/Specialty_Care/Stroke_and_Cerebrovascular_Center/Research/field_Attachments/tra-2p.jpg)](https://www.bmc.org/stroke-and-cerebrovascular-center/research/completed-studies/tra-2p-%E2%80%93-timi-50) [**TRA2P-TIMI50** : ensayo para evaluar los efectos de SCH530348 en la prevención del ataque cardíaco y el accidente cerebrovascular en pacientes con aterosclerosis](/stroke-and-cerebrovascular-center/research/completed-studies/tra-2p-%E2%80%93-timi-50)